中国人民解放军总医院，是中央军委联勤保障部队直属副军级单位，是中国人民解放军规模最大的综合性医院，中华人民共和国国家重要保健基地之一，负责中共中央、中央军委及其机关各部门医疗保健工作，负责全军各战区、军兵种疾病诊疗，同时收治地方病人。解放军总医院院部1957年以前曾用番号中国人民解放军第三〇一医院。

During the past decade, The Military General Hospital of Beijing PLA conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Military General Hospital of Beijing PLA" #1 sponsor was "Celgene" with 2 trials, followed by "FibroGen" with 2 trials sponsored, "Genesis Medtech Corporation" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "The George Institute" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Military General Hospital of Beijing PLA" #1 collaborator was "The First Hospital of Jilin University" with 3 trials as a collaborator, "Beijing Friendship Hospital" with 2 trials as a collaborator, "Henan Provincial People's Hospital" with 2 trials as a collaborator, "Ruijin Hospital" with 2 trials as a collaborator and "The Military General Hospital of Beijing, PLA" with 2 trials as a collaborator. Other collaborators include 82 different institutions and companies that were collaborators in the rest 91 trials.

According to Clinical.Site data, the most researched conditions in "The Military General Hospital of Beijing PLA" are "Anemia" (2 trials), "Diseases of Aortic Valve" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Advanced HCC" (1 trials) and "Adverse Drug Reaction" (1 trials). Many other conditions were trialed in "The Military General Hospital of Beijing PLA" in a lesser frequency.

Most popular intervention types in "The Military General Hospital of Beijing PLA" are "Drug" (14 trials), "Device" (5 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Chemotherapy" (2 trials), "FG-4592" (2 trials), "Transcatheter aortic valve replacement" (2 trials) and "Ustekinumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Military General Hospital of Beijing PLA" are 24 trials for "All" genders.

Currently, there are NaN active trials in "The Military General Hospital of Beijing PLA". 1 are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in The Military General Hospital of Beijing PLA, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Military General Hospital of Beijing PLA, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".